Abstract:Background: Esophageal cancer (EC) is highly ranked among all cancers in terms of its incidence and mortality rates. MicroRNAs (miRNAs) are considered to play key regulatory parts in EC. Multiple research studies have indicated the involvement of miR-3682-3p and four and a half LIM domain protein 1 (FHL1) in the achievement of tumors. The aim of this research was to clarify the significance of these genes and their possible molecular mechanism in EC. Methods: Data from a database and the tissue microarray were made to analyze the expression and clinical significance of miR-3682-3p or FHL1 in EC. Reverse transcription quantitative PCR and Western blotting were used to detect the expression levels of miR-3682-3p and FHL1 in EC cells. CCK8, EdU, wound healing, Transwell, flow cytometry, and Western blotting assays were performed to ascertain the biological roles of miR-3682-3p and FHL1 in EC cells. To confirm the impact of miR-3682-3p in vivo, a subcutaneous tumor model was created in nude mice. The direct interaction between miR-3682-3p and FHL1 was demonstrated through a luciferase assay, and the western blotting technique was employed to assess the levels of crucial proteins within the Wnt/β-catenin pathway. Results: The noticeable increase in the expression of miR-3682-3p and the decrease in the expression of FHL1 were observed, which correlated with a negative impact on the patients' overall survival. Upregulation of miR-3682-3p expression promoted the growth and metastasis of EC, while overexpression of FHL1 partially reversed these effects. Finally, miR-3682-3p motivates the Wnt/β-catenin signal transduction by directly targeting FHL1. Conclusion: MiR-3682-3p along the FHL1 axis activated the Wnt/β-catenin signaling pathway and thus promoted EC malignancy.

Roles of Wnt/β-catenin signaling pathway related microRNAs in esophageal cancer

The roles and clinical significance of microRNAs in cervical cancer.

MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

MicroRNAs target the Wnt/β-catenin signaling pathway to regulate epithelial-mesenchymal transition in cancer

Mir-942 Promotes Cancer Stem Cell-Like Traits In Esophageal Squamous Cell Carcinoma Through Activation Of Wnt/Beta-Catenin Signalling Pathway

The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer

MicroRNA-183 in Cancer Progression

Research Progress about Micrornas and Its Potential Use for the Detection, Diagnosis, Therapy and Prognosis of Esophageal Cancer

miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway

Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review

MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma

MiR-101-3p Promotes Tumor Cell Proliferation and Migration via the Wnt Signal Pathway in MNNG-Induced Esophageal Squamous Cell Carcinoma

Distinctive Microrna Signature Associated of Neoplasms with the Wnt/β-catenin Signaling Pathway

Expression of circRNA-0036474 in esophageal cancer and its clinical significance

miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment

Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile

miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer

MicroRNA-194 inhibits PRC1 activation of the Wnt/β-catenin signaling pathway to prevent tumorigenesis by elevating self-renewal of non-side population cells and side population cells in esophageal cancer stem cells

Mir-630 Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma